Lebwohl MG, Blauvelt A, Bagel J, Gogineni R, et al. Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over five years in patients living with obesity. Br J Dermatol 2025 Oct 14:ljaf392. doi: 10.1093.
PMID: 41092123